Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Endometriosis Pain
NCT00115661Phase 2Terminated
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jul 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rosiglitazone in endometriosis, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Visual Analog Scale Diary at 6 months. Started Jul 2005; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00115661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115661.